Autosomal dominant optic atrophy caused by six novel pathogenic OPA1 variants and genotype-phenotype correlation analysis

被引:3
|
作者
Han, Jinfeng [1 ,2 ]
Li, Ya [1 ,3 ]
You, Ya [1 ,3 ]
Fan, Ke [1 ,3 ]
Lei, Bo [1 ,2 ,3 ]
机构
[1] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Dept Ophthalmol, Zhengzhou 450003, Peoples R China
[2] Zhengzhou Univ, Acad Med Sci, Zhengzhou 450000, Peoples R China
[3] Henan Prov Peoples Hosp, Henan Eye Hosp, Henan Eye Inst, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
ADOA; OPA1; Variant; Targeted next-generation sequencing; Chinese; Optic nerve; CHROMOSOME 3Q REGION; MITOCHONDRIAL MORPHOLOGY; MUTATIONS; GENE; SPECTRUM; FEATURES; DISEASE;
D O I
10.1186/s12886-022-02546-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To describe the genetic and clinical features of nineteen patients from eleven unrelated Chinese pedigrees with OPA1-related autosomal dominant optic atrophy (ADOA) and define the phenotype-genotype correlations. Methods Detailed ophthalmic examinations were performed. Targeted next-generation sequencing (NGS) was conducted in the eleven probands using a custom designed panel PS400. Sanger sequencing and cosegregation were used to verify the identified variants. The pathogenicity of gene variants was evaluated according to American College of Medical Genetics and Genomics (ACMG) guidelines. Results Nineteen patients from the eleven unrelated Chinese ADOA pedigrees had impaired vision and optic disc pallor. Optical coherence tomography showed significant thinning of the retinal nerve fiber layer. The visual field showed varying degrees of central or paracentral scotoma. The onset of symptoms occurred between 3 and 24 years of age (median age 6 years). Eleven variants in OPA1 were identified in the cohort, and nine novel variants were identified. Among the novel variants, two splicing variants c.984 + 1_984 + 2delGT, c.1194 + 2 T > C, two stop-gain variants c.1937C > G, c.2830G > T, and one frameshift variant c.2787_2794del8, were determined to be pathogenic based on ACMG. A novel splicing variant c.1316-10 T > G was determined to be likely pathogenic. In addition, a novel missense c.1283A > C (p.N428T) and two novel splicing variants c.2496G > A and c.1065 + 5G > C were of uncertain significance. Conclusions Six novel pathogenic variants were identified. The findings will facilitate genetic counselling by expanding the pathogenic mutation spectrum of OPA1.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Peripapillary capillary network in dominant optic atrophy linked to OPA1 gene
    Rahhal-Ortuno, Miriam
    Avino-Martinez, Juan Aurelio
    Fernandez-Santodomingo, Alex Samir
    Aguilar-Gonzalez, Marina
    Placinta-Tat, Ioan Alexandru
    Espana-Gregori, Enrique
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (01) : NP19 - NP22
  • [42] OPA1 Mutations Associated with Dominant Optic Atrophy Influence Optic Nerve Head Size
    Barboni, Piero
    Carbonelli, Michele
    Savini, Giacomo
    Foscarini, Beatrice
    Parisi, Vincenzo
    Valentino, Maria L.
    Carta, Arturo
    De Negri, Annamaria
    Sadun, Federico
    Zeviani, Massimo
    Sadun, Alfredo A.
    Schimpf, Simone
    Wissinger, Bernd
    Carelli, Valerio
    OPHTHALMOLOGY, 2010, 117 (08) : 1547 - 1553
  • [43] Loss of functional OPA1 unbalances redox state: implications in dominant optic atrophy pathogenesis
    Millet, Aurelie M. C.
    Bertholet, Ambre M.
    Daloyau, Marlene
    Reynier, Pascal
    Galinier, Anne
    Devin, Anne
    Wissinguer, Bernd
    Belenguer, Pascale
    Davezac, Noelie
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (06): : 408 - 421
  • [44] Genotype-phenotype correlation in children with autosomal dominant polycystic kidney disease
    Fencl, Filip
    Janda, Jan
    Blahova, Kveta
    Hribal, Zdenek
    Stekrova, Jitka
    Puchmajerova, Alena
    Seeman, Tomas
    PEDIATRIC NEPHROLOGY, 2009, 24 (05) : 983 - 989
  • [45] Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder
    Liskova, Petra
    Ulmanova, Olga
    Tesina, Petr
    Melsova, Hana
    Diblik, Pavel
    Hansikova, Hana
    Tesarova, Marketa
    Votruba, Marcela
    ACTA OPHTHALMOLOGICA, 2013, 91 (03) : E225 - E231
  • [46] First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report
    Weisschuh, Nicole
    Mazzola, Pascale
    Heinrich, Tilman
    Haack, Tobias
    Wissinger, Bernd
    Tonagel, Felix
    Kelbsch, Carina
    BMC MEDICAL GENETICS, 2020, 21 (01)
  • [47] Genomics combined with a protein informatics platform to assess a novel pathogenic variant c.1024 A>G (p.K342E) in OPA1 in a patient with autosomal dominant optic atrophy
    Ahuja, Abhimanyu S.
    Selvam, Pavalan
    Vadlamudi, Charitha
    Chopra, Hayley
    Richter, John E., Jr.
    Macklin, Sarah K.
    Samreen, Ayesha
    Helmi, Haytham
    Mohammaad, Ahmed N.
    Hines, Stephanie
    Davila, Maria C.
    Atwal, Paldeep S.
    Caulfield, Thomas R.
    OPHTHALMIC GENETICS, 2020, 41 (06) : 563 - 569
  • [48] Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy
    Nolli, Cecilia
    Goffrini, Paola
    Lazzaretti, Mirca
    Zanna, Claudia
    Vitale, Rita
    Lodi, Tiziana
    Baruffini, Enrico
    MITOCHONDRION, 2015, 25 : 38 - 48
  • [49] Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis
    Del Dotto, Valentina
    Carelli, Valerio
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [50] Pyruvate carboxylase deficiency type A and type C: Characterization of five novel pathogenic variants in PC and analysis of the genotype-phenotype correlation
    Coci, Emanuele G.
    Gapsys, Vytautas
    Shur, Natasha
    Shin-Podskarbi, Yoon
    de Groot, Bert L.
    Miller, Kathryn
    Vockley, Jerry
    Sondheimer, Neal
    Ganetzky, Rebecca
    Freisinger, Peter
    HUMAN MUTATION, 2019, 40 (06) : 816 - 827